Utilization Patterns of IV Iron and Erythropoiesis Stimulating Agents in Anemic Chronic Kidney Disease Patients: A Multihospital Study

Table 7

Mean days of therapy/100 patient days by drug group.

Variable	IV Iron +ESA therapy		ESA therapy alone
	Mean	SD	Mean	SD	𝑃-value
ESA DOTs/100 PDs	8.66	20.28	12.36	21.92	<0.001
IV Iron DOTs/100 PDs	30.41	28.20	NA	NA	NA

IV: Intravenous.
ESA: Erythropoiesis stimulating agents.
DOTs: Days of therapy.
PDs: Patient days.